Igor Bilinsky Iovance Biotherapeutics, Inc. (IOVA) insider trading activity

Igor Bilinsky is Chief Operating Officer of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 58,774 shares of IOVA, which is worth approximately $352,056. The most recent transaction as insider was on Jan 14, 2025, when has been sold 1,578 shares (Common Stock) at a price of $5.89 per share, resulting in proceeds of $9,294. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.8K

5.32% 3M change

96.79% 12M change

Total Value Held $352,056

IGOR BILINSKY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 14 2025	SELL Payment of exercise price or tax liability	$9,294 $5.89 p/Share	1,578 Reduced 2.61%	58,774 Common Stock
Jan 14 2025	BUY Exercise of conversion of derivative security	-	2,813 Added 4.45%	60,352 Common Stock
Dec 02 2024	SELL Payment of exercise price or tax liability	$16,180 $9.07 p/Share	1,784 Reduced 3.01%	57,539 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	-	3,516 Added 5.6%	59,323 Common Stock
Oct 14 2024	SELL Payment of exercise price or tax liability	$13,951 $9.77 p/Share	1,428 Reduced 2.49%	55,807 Common Stock
Oct 14 2024	BUY Exercise of conversion of derivative security	-	2,813 Added 4.68%	57,235 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$148,373 $10.85 p/Share	13,675 Reduced 20.08%	54,422 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	-	26,954 Added 28.9%	66,313 Common Stock
Jul 15 2024	SELL Payment of exercise price or tax liability	$12,395 $8.68 p/Share	1,428 Reduced 3.35%	41,143 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	-	2,813 Added 6.2%	42,571 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$14,932 $8.37 p/Share	1,784 Reduced 4.29%	39,758 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	-	3,516 Added 7.8%	41,542 Common Stock
Apr 15 2024	SELL Payment of exercise price or tax liability	$16,967 $11.89 p/Share	1,427 Reduced 3.62%	38,026 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	-	2,812 Added 6.65%	39,453 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$123,587 $16.96 p/Share	7,287 Reduced 16.59%	36,641 Common Stock
Mar 04 2024	BUY Exercise of conversion of derivative security	-	14,061 Added 24.25%	43,928 Common Stock
Jan 16 2024	SELL Payment of exercise price or tax liability	$13,199 $8.37 p/Share	1,577 Reduced 5.02%	29,867 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	-	2,813 Added 8.21%	31,444 Common Stock
Oct 16 2023	SELL Payment of exercise price or tax liability	$4,980 $3.57 p/Share	1,395 Reduced 4.65%	28,631 Common Stock
Oct 16 2023	BUY Exercise of conversion of derivative security	-	2,813 Added 8.57%	30,026 Common Stock
Jul 14 2023	SELL Payment of exercise price or tax liability	$10,825 $7.76 p/Share	1,395 Reduced 4.88%	27,213 Common Stock
Jul 14 2023	BUY Exercise of conversion of derivative security	-	2,813 Added 8.95%	28,608 Common Stock
Apr 14 2023	SELL Payment of exercise price or tax liability	$7,867 $5.64 p/Share	1,395 Reduced 5.13%	25,795 Common Stock
Apr 14 2023	BUY Exercise of conversion of derivative security	-	2,812 Added 9.37%	27,190 Common Stock
Jan 17 2023	SELL Payment of exercise price or tax liability	$30,034 $6.43 p/Share	4,671 Reduced 16.08%	24,378 Common Stock

Also insider at

ONCT

Oncternal Therapeutics, Inc. Healthcare

Chief Business Officer

Igor Bilinsky

Chief Operating Officer

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Value

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA

Account